Medical Devices

Byron Medical’s exclusive Zumax distribution deal signals a strategic shift in the ANZ dental market, bringing advanced ergonomics to general practice.

Gardner Medical Instruments just secured FDA Class I registration for a system that maintains continuous ventilation during intubation. Will it change the standard of care?

By targeting the structural flaws behind debilitating pulsatile tinnitus, a Silicon Valley startup is shifting how neurovascular care is delivered and funded.

Aerospace-grade metals have turned stuck rings into medical emergencies. A new study reveals how a Canadian medtech startup is closing the dangerous technology gap in our trauma bays.

A new blood test promises to predict scoliosis progression with perfect accuracy. But do the corporate ties and statistical claims hold up to scrutiny?

With a former FDA director at the helm, Keyron is positioning its reversible metabolic implant to disrupt the massive, drug-dominated weight-loss market.

At 95, William Shatner is fronting Audien Hearing's new campaign. But behind the celebrity endorsement lies a fierce battle for a $1.4 billion market.

FastWave Medical's Sola system posts a 96.4% success rate, signaling a high-speed, laser-driven disruption in the multi-billion-dollar lithotripsy market.

As GLP-1 drugs boom, a new ancillary market is emerging to treat their side effects. French CDMO ANJAC is building the infrastructure to power it.

Despite a £20M+ rollout of public defibrillators across the UK, public hesitation leaves life-saving tech unused. Can smart voice coaches bridge the gap?

As NYU Langone poaches top surgical talent from rival HSS, a new era of 3D-printed joints and shock-absorbing implants promises to delay the replacement age.

The Ontario Brain Institute has awarded $500,000 to five neurotechnology startups, aiming to keep homegrown IP in Canada and bridge the commercialization gap.

Dina Shanowitz’s Stevie Award nomination highlights a pivotal shift in maternal health: prioritizing insurance-backed access over premium out-of-pocket luxury.

New clinical data reveals that combining motion preservation with anatomical alignment significantly outperforms traditional spinal fusion outcomes.

Profusa's injectable biosensor cleared a major EU regulatory hurdle, but severe cash constraints and a massive pivot raise existential questions for the company.

Türkiye’s first proton therapy center at Çam ve Sakura City Hospital proves that shrinking medical tech is the key to expanding global cancer care access.

As the global population ages, advanced adult briefs are transforming home healthcare. Discover the hidden costs and high-tech solutions driving a $30B market.

Armed with $56 million, Anaconda Biomed is challenging MedTech giants by reimagining mechanical thrombectomy and solving the embolic trap in stroke care.

Smith+Nephew's newly FDA-cleared LANDMARK knee system pairs 3D-printed implants with compact robotics to target the booming outpatient surgery market.

Koning Health’s recent TGA approval for its compression-free breast CT system signals a strategic shift in diagnostic imaging and patient compliance.